263 related articles for article (PubMed ID: 32481723)
1. Theragnostic Aspects and Radioimmunotherapy in Pediatric Tumors.
Cimini A; Ricci M; Chiaravalloti A; Filippi L; Schillaci O
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32481723
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic advances of nuclear medicine in oncology].
Valdés Olmos RA; Hoefnagel CA; Bais E; Boot H; Taal B; de Kraker J; Vote PA
Rev Esp Med Nucl; 2001 Dec; 20(7):547-57. PubMed ID: 11709141
[TBL] [Abstract][Full Text] [Related]
3. Is there a role for PET-CT and SPECT-CT in pediatric oncology?
Biermann M; Schwarzlmüller T; Fasmer KE; Reitan BC; Johnsen B; Rosendahl K
Acta Radiol; 2013 Nov; 54(9):1037-45. PubMed ID: 23319723
[TBL] [Abstract][Full Text] [Related]
4. Radiation doses for pediatric nuclear medicine studies: comparing the North American consensus guidelines and the pediatric dosage card of the European Association of Nuclear Medicine.
Grant FD; Gelfand MJ; Drubach LA; Treves ST; Fahey FH
Pediatr Radiol; 2015 Apr; 45(5):706-13. PubMed ID: 25367355
[TBL] [Abstract][Full Text] [Related]
5. Imaging of somatostatin receptors by indium-111-pentetreotide correlates with quantitative determination of somatostatin receptor type 2 gene expression in neuroblastoma tumors.
Briganti V; Sestini R; Orlando C; Bernini G; La Cava G; Tamburini A; Raggi CC; Serio M; Maggi M
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2385-91. PubMed ID: 9815638
[TBL] [Abstract][Full Text] [Related]
6. Molecular Imaging in Pediatric Brain Tumors.
Chiaravalloti A; Filippi L; Ricci M; Cimini A; Schillaci O
Cancers (Basel); 2019 Nov; 11(12):. PubMed ID: 31771237
[TBL] [Abstract][Full Text] [Related]
7. Value of 18F-FDG PET and PET/CT for evaluation of pediatric malignancies.
Uslu L; Donig J; Link M; Rosenberg J; Quon A; Daldrup-Link HE
J Nucl Med; 2015 Feb; 56(2):274-86. PubMed ID: 25572088
[TBL] [Abstract][Full Text] [Related]
8. Next-level precision medicine: why the theragnostic approach is the future.
Iacomino A; Rapa M; Gatta G; DI Grezia G; Cuccurullo V
Q J Nucl Med Mol Imaging; 2024 Jun; 68(2):152-159. PubMed ID: 38860276
[TBL] [Abstract][Full Text] [Related]
9. Applications of nuclear medicine in pediatric oncology.
Connolly LP; Drubach LA; Ted Treves S
Clin Nucl Med; 2002 Feb; 27(2):117-25. PubMed ID: 11786742
[TBL] [Abstract][Full Text] [Related]
10. Minimizing and communicating radiation risk in pediatric nuclear medicine.
Fahey FH; Treves ST; Adelstein SJ
J Nucl Med; 2011 Aug; 52(8):1240-51. PubMed ID: 21764783
[TBL] [Abstract][Full Text] [Related]
11. Single-photon emission computed tomography tracers in the diagnostics of neuroendocrine tumors.
Pepe G; Bombardieri E; Lorenzoni A; Chiti A
PET Clin; 2014 Jan; 9(1):11-26. PubMed ID: 25029930
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies and neuroblastoma.
Miraldi F
Semin Nucl Med; 1989 Oct; 19(4):282-94. PubMed ID: 2678480
[TBL] [Abstract][Full Text] [Related]
13. The role of radioisotopes in radiation oncology.
Park CH
Semin Oncol; 1997 Dec; 24(6):639-54. PubMed ID: 9422261
[TBL] [Abstract][Full Text] [Related]
14. A comparison of targeting of neuroblastoma with mIBG and anti L1-CAM antibody mAb chCE7: therapeutic efficacy in a neuroblastoma xenograft model and imaging of neuroblastoma patients.
Hoefnagel CA; Rutgers M; Buitenhuis CK; Smets LA; de Kraker J; Meli M; Carrel F; Amstutz H; Schubiger PA; Novak-Hofer I
Eur J Nucl Med; 2001 Mar; 28(3):359-68. PubMed ID: 11315605
[TBL] [Abstract][Full Text] [Related]
15. Nuclear medicine procedures and neuroblastoma in childhood. Their value in the diagnosis, staging and assessment of response to therapy.
Boubaker A; Bischof Delaloye A
Q J Nucl Med; 2003 Mar; 47(1):31-40. PubMed ID: 12714952
[TBL] [Abstract][Full Text] [Related]
16. Pediatrics: diagnosis of neuroblastoma.
Sharp SE; Gelfand MJ; Shulkin BL
Semin Nucl Med; 2011 Sep; 41(5):345-53. PubMed ID: 21803184
[TBL] [Abstract][Full Text] [Related]
17. Bevacizumab-associated Bowel Microperforation in a Patient With Neuroblastoma.
Glincher R; Price AP; LaQuaglia MP; Kushner BH; Modak S
J Pediatr Hematol Oncol; 2018 Aug; 40(6):e394-e396. PubMed ID: 28816801
[TBL] [Abstract][Full Text] [Related]
18. Paediatric nuclear medicine imaging.
Biassoni L; Easty M
Br Med Bull; 2017 Sep; 123(1):127-148. PubMed ID: 28910997
[TBL] [Abstract][Full Text] [Related]
19. Development of a Theranostic Convergence Bioradiopharmaceutical for Immuno-PET Based Radioimmunotherapy of L1CAM in Cholangiocarcinoma Model.
Song IH; Jeong MS; Hong HJ; Shin JI; Park YS; Woo SK; Moon BS; Kim KI; Lee YJ; Kang JH; Lee TS
Clin Cancer Res; 2019 Oct; 25(20):6148-6159. PubMed ID: 31337646
[TBL] [Abstract][Full Text] [Related]
20. FDG-PET/CT in pediatric solid tumors.
Franzius C
Q J Nucl Med Mol Imaging; 2010 Aug; 54(4):401-10. PubMed ID: 20823808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
